BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stowman AM, Hsia L, Kanner WA, Mahadevan MS, Bullock GC, Patterson JW. Multiple cutaneous lymphoproliferative disorders showing a retained tumor clone by T-cell receptor gene rearrangement analysis: a case series of four patients and review of the literature. Int J Dermatol 2016;55:e62-71. [DOI: 10.1111/ijd.12847] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Diaz de la Pinta FJ, Machan S, Manso Alonso R, Carvajal N, Nieves Salgado R, Piris MÁ, Rodríguez Pinilla SM. DUSP22 Rearrangement in primary cutaneous T-cell Lymphoma with features intermediate between Mycosis Fungoides, Anaplastic Large-cell Lymphoma and Lymphomatoid Papulosis. Histopathology 2021. [PMID: 34252219 DOI: 10.1111/his.14448] [Reference Citation Analysis]
2 Runge JS, Novice ML, Briones N, Williams K, Lowe L, Boyer DF, Wilcox RA, Tejasvi T, Hristov AC. Patch/plaque mycosis-fungoides-like presentations of DUSP22-translocated T-cell lymphomas. J Cutan Pathol 2021. [PMID: 34699105 DOI: 10.1111/cup.14156] [Reference Citation Analysis]
3 Xerri L, Adélaïde J, Avenin M, Guille A, Taix S, Bonnet N, Carbuccia N, Garnier S, Mescam L, Murati A, Chaffanet M, Coso D, Bouabdallah R, Bertucci F, Birnbaum D. Common origin of sequential cutaneous CD30+ lymphoproliferations with nodal involvement evidenced by genome-wide clonal evolution. Histopathology 2019;74:654-62. [DOI: 10.1111/his.13783] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
4 Brown RA, Fernandez-Pol S, Kim J. Primary cutaneous anaplastic large cell lymphoma. J Cutan Pathol 2017;44:570-7. [PMID: 28342276 DOI: 10.1111/cup.12937] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
5 Liu R, Zhao J, He K, Zhang X, Chang L, Xiang G. Determination of Eupatilin in Folium artemisiae Argyi and Its Inhibitory Effect on Hepatoma Cells. Pharmacogn Mag 2018;14:129-33. [PMID: 29576713 DOI: 10.4103/pm.pm_472_16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Cieza-díaz DE, Prieto-torres L, Rodríguez-pinilla SM, Córdoba Mascuñano R, Manso Alonso R, Machan S, Piris Pinilla MÁ, Requena Caballero L. Mycosis Fungoides Associated With Lesions in the Spectrum of Primary Cutaneous CD30+ Lymphoproliferative Disorders: The Same Process or 3 Coexisting Lymphomas? The American Journal of Dermatopathology 2019;41:846-50. [DOI: 10.1097/dad.0000000000001423] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Sundram U. Cutaneous Lymphoproliferative Disorders: What's New in the Revised 4th Edition of the World Health Organization (WHO) Classification of Lymphoid Neoplasms. Adv Anat Pathol 2019;26:93-113. [PMID: 30199396 DOI: 10.1097/PAP.0000000000000208] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Dulmage B, Geskin L, Guitart J, Akilov OE. The biomarker landscape in mycosis fungoides and Sézary syndrome. Exp Dermatol 2017;26:668-76. [PMID: 27897325 DOI: 10.1111/exd.13261] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]